Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Rare Diseases Treatment Market by Drug Type (Biological Drugs, Non-Biological Drugs), Therapeutic Area (Cancer, Cardiovascular Conditions, Endocrine...
-
Rockville, MD, March 18, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the The global rare neurological disease treatment market was valued...
-
Dublin, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The "Orphan Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Orphan Drugs was...
-
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Rare Diseases Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Rare Diseases Market is forecast to...
-
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
-
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Rare Disease Treatment Market (2023-2028) by Therapeutic Area, Drug Type, Drug Class, Mode of Administration, Distribution Channel, and...
-
Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Orphan Drugs" report has been added to ResearchAndMarkets.com's offering. The global orphan drugs market was valued at an...
-
Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The "Orphan Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global orphan drugs market is expected to grow...
-
Washington, DC, June 15, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Orotic Aciduria Market By Drug Type (Uridine Monophosphate, Cytidine Monophosphate,...
-
WASHINGTON, Feb. 08, 2023 (GLOBE NEWSWIRE) -- According to the report published by Vantage Market Research, the global Orphan Drugs Market was estimated at $ 112.36 Billion in 2021 and is expected...